Differential Prognostic Value of Revascularization for Coronary Stenosis with Intermediate Fractional Flow Reserve by Coronary Flow Reserve

[Speaker] Juwon Kim
Juwon Kim¹, Doosup Shin², Joo Myung Lee,¹, Seung Hun Lee³, David Hong¹, Ki Hong Choi¹, Doyeon Hwang⁴, Ji-Hyun Jung⁵, Joon-Hyung Doh⁶, Hyun Kuk Kim⁷, Chang-Wook Nam⁸, Eun-Seok Shin⁹, on behalf of ILIAS registry invetigators
¹Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; ²Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA; ³Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea; ⁴Seoul National University Hospital, Department of Internal Medicine, Cardiovascular Center, Seoul, Korea; ⁵Sejong General Hospital, Sejong Heart Institute, Bucheon, Korea; ⁶Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea; ⁷Department of Internal Medicine and Cardiovascular Center, Chosun University Hospital, University of Chosun College of Medicine, Gwangju, Korea; ⁸Department of Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea; ⁹Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

Effects of Platelet Reactivity Combined with CYP2C19 Genotype on Outcomes of Clopidogrel Treatment: Insights from PTRG-DES Registry

[Speaker] Ho Sung Jeon
Se-Eun Kim, MD, a,b Ho-Sung Jeon, MD,a Tae-Hwa Go, MS,c Young In Kim, MD,a Jun?Won Lee, MD,a Jung-Hee Lee, MD,a Young Jin Youn, MD,a Byeong-Keuk Kim, MD,b Hyung Joon Joo, MD,c Kiyuk Chang, MD,d Yongwhi Park, MD,e Young Bin Song, MD,f Jung-Won Suh, MDg, Sang Yup Lee, MD,h Jung Rae Cho, MD,i Ae-Young Her, MD,j Young-Hoon Jeong, MD,k Hyo-Soo Kim, MD,l Moo Hyun Kim, MD,m Eun-Seok Shin, MD,n Do-Sun Lim, MDc Sung Gyun Ahn, MD,a; for the PTRG-DES Registry Investigators
a, b Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju Severance Christian Hospital, Wonju, South Korea; cDepartment of Biostatistics, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea bSeverance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea Seoul, Korea; cDepartment of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea; dDivision of Cardiology, Department of Internal Medicine, College of Medicine, Catholic University of Korea, Seoul, South Korea; eDepartment of Internal Medicine, Gyeongsang National University School of Medicine and Cardiovascular Center, Gyeongsang National University Changwon Hospital, Changwon, South Korea; fDivision of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; gDepartment of Internal Medicine, Seoul National University College of Medicine and Department of Cardiology, Seoul National University Bundang Hospital, Seongnam, South Korea; hDivision of Cardiology, Chung-Ang University Gwangmyeong Hospital and Department of Internal Medicine, Chung-Ang University College of Medicine, Gwangmyeong; iCardiology Division, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea; jDivision of Cardiology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, South Korea; kCAU Thrombosis and Biomarker Center, Chung-Ang University Gwangmyeong Hospital and Department of Internal Medicine, Chung-Ang University College of Medicine, Gwangmyeong; lDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea; mDepartment of Cardiology, Dong-A University Hospital, Busan, South Korea; nDivision of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Second-Generation Drug-Eluting Stents in Real-World Practice

[Speaker] Hyun Sung Joh
Hyun Sung Joh, MD^1*, Joo Myung Lee, MD, MPH, PhD^1*, Ki Hong Choi, MD, PhD¹, David Hong, MD¹, Taek Kyu Park, MD¹, Jeong Hoon Yang, MD, PhD¹, Young Bin Song, MD, PhD¹, Jin-Ho Choi, MD, PhD¹, Seung-Hyuk Choi, MD, PhD¹, Jin-Ok Jeong, MD, PhD², Jong-Young Lee, MD, PhD³, Young Jin Choi, MD, PhD⁴, Jei-Keon Chae, MD, PhD⁵, Seung-Ho Hur, MD, PhD⁶, Jang-Whan Bae, MD, PhD⁷, Ju-Hyeon Oh, MD, PhD⁸, Hyun-Jong Lee, MD, PhD⁴, Ho-Jun Jang, MD⁴, Joo-Yong Hahn, MD, PhD¹, Hyeon-Cheol Gwon, MD, PhD¹, On behalf of the SMART-REWARD Investigators.
¹Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; ²Department of Cardiology in Internal Medicine, School of Medicine, Chungnam National University, Chungnam National University Hospital, Daejeon, Korea; ³Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, School of Medicine, Sungkyunkwan University, Seoul, Korea; ⁴Division of Cardiology, Department of Internal Medicine, Sejong General Hospital, Bucheon, Korea; ⁵Division of Cardiology, Department of Internal Medicine, Chonbuk National University Hospital and Chonbuk National University Medical School, Jeonju, Korea; ⁶Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea; ⁷Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea et al.

Long-term clinical outcomes after endovascular therapy for subclavian artery stenosis

[Speaker] Yong-Joon Lee
Yong-Joon Lee, Joongmin Kim, Jong-Il Park, Young-Guk Ko, Chul-Min Ahn
Severance Hospital